The article reports that clinical trial and observational data describe menstrual irregularities in roughly 15 to 30 percent of women starting GLP-1 therapy, with most changes appearing in the first three months
Retatrutide is a once-weekly injection that mimics three hormones involved in appetite, blood sugar, and how the body uses energy: GLP-1: lowers appetite and blood sugar GIP: lowers appetite and blood sugar Glucagon: increases energy expenditure and the breakdown of stored fat, including fat in the liver The glucagon component is what separates retatrutide from semaglutide, which mimics one hormone (GLP-1), and tirzepatide, which mimics two (GLP-1 and GIP)
Mijn huid vlamt op bij warmte , zon, pikant eten, alcohol maar echt heel heftig
The peptide receptors that semaglutide activatesparticularly GIPRregulate hunger signals and glucose handling throughout your body
Just when we all thought Tirzepatide (Mounjaro) was an amazing weight & fat loss peptide, medicine continues to evolve & here we are at the new and improved version called Retatrutide & Pemvidutide